fbpx
Gaming

The Legend of Zelda: Tears of the Kingdom is the fastest-selling game in the series

It's also the fastest-selling Nintendo game, period, in the Americas

The Legend of Zelda: Tears of the Kingdom Link riding horse

Nintendo has announced that The Legend of Zelda: Tears of the Kingdom has hit 10 million copies sold worldwide since its release on May 12th. This makes it the fastest-selling game in the Zelda series, and the fastest-selling Nintendo game, period, in the Americas.

The game is no doubt benefiting from the fact that it’s coming out at the tail end of the Nintendo Switch’s lifecycle, so the console-handheld hybrid has an installed base of over 125 million at this point. By contrast, Tears of the Kingdom‘s predecessor, Breath of the Wild, was a Switch launch title, so it had a comparatively smaller launch but has remained a consistent Switch top-seller ever since. Breath of the Wild is currently sitting at over 30 million copies sold (around 29 million on the Switch, and just over one million on Wii U), so it seems safe to assume an even bigger cume for Tears of the Kingdom. 

Tears of the Kingdom is believed to be the last major exclusive for the Switch outside of smaller titles like July’s Pikmin 4, given the Switch’s age. However, Nintendo says new hardware won’t come until after March 2024 at the earliest.

Either way, Tears of the Kingdom should tide Nintendo fans over for quite some time, considering it offers well over 100 hours’ worth of content. In particular, players have gone wild with building the most elaborate and goofy constructs possible, including laser-emitting robots and giant flaming penises.

For more on The Legend of Zelda: Tears of the Kingdom, check out our full review, in which Patrick O’Rourke calls it better than Breath of the Wild “in every way.” We also wrote about the return of midnight launches for Tears of the Kingdom and took a stroll down Zelda memory lane with Canadian actor and Nintendo superfan Maitreyi Ramakrishnan.

Image credit: Nintendo

Source: Nintendo

MobileSyrup may earn a commission from purchases made via our links, which helps fund the journalism we provide free on our website. These links do not influence our editorial content. Support us here.

Related Articles

Comments